• 首页
  • 期刊简介
  • 编委会
    第六届编委会
  • 投稿须知
    文章要求
    投稿指南
    发表学术论文“五不准”
  • 本刊稿约
  • 期刊公告
  • 联系我们
引用本文:
【打印本页】   【下载PDF全文】     【下载PDF阅读器】  【关闭】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 2610次   下载 0次 本文二维码信息
码上扫一扫!
分享到: 微信 更多
字体:加大+|默认|缩小-
不同剂量依那西普治疗类风湿关节炎的系统评价
凌雪梅; 田伟1,2
1.四川大学华西医院期刊社;2.四川省医学科学院·四川省人民医院运营管理部
摘要:
目的系统评价不同剂量依那西普治疗类风湿关节炎的有效性和安全性。方法计算机检索Medline、Embase、Cochrane图书馆、中国期刊全文数据库、维普数据库、中国生物医学文献数据库、万方数据库,检索时限均从建库起截止2016年10月,根据Cochrane系统评价方法对纳入的随机对照试验进行方法学质量评价,并用RevMan 5.3软件进行Meta分析。结果共纳入7个研究,1353例患者。结果显示,在ACR方面,依那西普50mg/周组仅在ACR50(第13周和104周)优于依那西普20mg/周组,差异有统计学意义(P<0.05),其他组间差异均无统计学意义(P>0.05);在CRP、ESR、RF和ADR方面,各组间差异均无统计学意义(P>0.05)。结论不同剂量依那西普治疗类风湿关节炎的疗效和安全性的差异不显著,可适当选用低剂量方案,药物使用更加经济。
关键词:  依那西普  类风湿关节炎  系统评价
DOI:
分类号:
基金项目:
Systematic Review of Different Doses of Etanercept in the Treatment of Rheumatoid Arthritis
Ling Xuemei;Tian Wei1,2
1.Periodical Press of West China Hospital of Sichuan University;2.Sichuan Academy of Medical Sciences,Operation Management Department of Sichuan Provincial People’s Hospital
Abstract:
Objective To evaluate the efficacy and safety of different doses of etanercept in the treatment of rheumatoid arthritis.Methods We searched Medline,Embase,Cochrane library,China Journal Full-text Database,VIP database,Chinese biomedical literature database and Wanfang database,and the retrieval time was from the establishment of the database until October2016.The methodological quality of randomized controlled trials included was evaluated according to the Cochrane system evaluation method,and we used RevMan 5. 3 software to make Meta-analysis.Results A total of 7 studies and 1353 patients were included.The results showed that in ACR,etanercept 50mg/week group was better than that of etanercept 20mg/week group only in ACR50( the thirteenth week and 104 th week),the difference was statistically significant( P<0. 05),the differences between other groups were not statistically significant( P>0. 05); in CRP,ESR,RF and ADR,There was no statistical difference between the groups( P>0. 05).Conclusion The difference of efficacy and safety of different doses of etanercept in the treatment of rheumatoid arthritis is not significant,so low dose program can be appropriately selected to make the use of drugs more economical.
Key words:  etanercept  rheumatoidarthritis  systematicreview
您是本站第  88056923  位访问者!蜀ICP备11024768号
版权所有:(C)四川省医疗卫生服务指导中心 2010 CopyRight http://scmj.scyx.org.cn/ all right reserved.
地址:成都市玉林南街2号附3号   电话:028-86136765 邮编:610041
技术支持:北京勤云科技发展有限公司